Fetal medicine, also known as maternal-fetal medicine, specializes in managing high-risk pregnancies and diagnosing fetal abnormalities. Specialists use advanced ultrasound, amniocentesis, and genetic testing to monitor fetal development and guide treatment decisions before and after birth.



Hi, Welcome to icliniq.com. First of all, understand clearly the findings in your sonography and try to understand them. Choroid plexus cyst and intracardiac echogenic focus, when they are single, are termed as isolated …

Hello, Welcome to icliniq.com. The number of weeks will be counted according to your scan date. So, according to this, your TIFFA (targeted imaging for fetal anomalies) scan will be dated. The TIFFA or anomaly scan, whic…

Hello, Welcome to icliniq.com. I have gone through your query and understand your concern. Your latest ultrasound shows reduced blood flow to the baby, along with hydrocephalus (the buildup of cerebrospinal fluid (CSF) i…

Hi, Welcome to icliniq.com. I have gone through your reports (attachment removed to protect patient identity) in toto. At 26 weeks of gestation, the overall growth of the fetus is fine. But the concern here is a hypoplas…

Hi, Welcome to icliniq.com. I can understand your concern. Thanks for sharing the fetal heart strip. Here is a simple and summarized interpretation based on the visible strip: Key observations: Fetal heart rate (FHR): Th…

A fetal medicine specialist manages high-risk pregnancies, performs detailed fetal ultrasounds, conducts prenatal diagnostic tests like amniocentesis and chorionic villus sampling, diagnoses fetal abnormalities, and coordinates multidisciplinary care for complex cases.
Referral is recommended if you have a history of pregnancy complications, abnormal prenatal screening results, multiple gestations (twins or more), pre-existing medical conditions like diabetes or hypertension, advanced maternal age, or if a fetal abnormality is suspected.
The nuchal translucency (NT) scan is an ultrasound performed between 11 and 14 weeks of pregnancy that measures fluid at the back of the baby's neck. An increased measurement may indicate a higher risk for chromosomal conditions like Down syndrome.
Some conditions can be treated in utero through fetal surgery or interventional procedures, such as laser therapy for twin-to-twin transfusion syndrome, placement of shunts for urinary obstructions, or blood transfusions for fetal anemia. Treatment availability depends on the specific condition.
Amniocentesis carries a small risk of miscarriage, estimated at about 0.1 to 0.3 percent. It is performed under ultrasound guidance to minimize risks and is recommended when the diagnostic benefit outweighs the procedural risk, such as confirming chromosomal abnormalities.